| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |